Cryoablation and immunotherapy: an overview of evidence on its synergy

[1]  Prostate Cryotherapy , 2019, Operative Dictations in Urologic Surgery.

[2]  T. Si,et al.  The oncologic results of cryoablation in prostate cancer patients with bone metastases , 2018, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[3]  Alexander J. King,et al.  Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma. , 2018, Radiology.

[4]  P. Ott,et al.  Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  J. Ludwig,et al.  Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study. , 2018, Radiology.

[6]  Yi-Chen Yeh,et al.  Mutation load estimation model as a predictor of the response to cancer immunotherapy , 2018, npj Genomic Medicine.

[7]  E. Soule,et al.  Percutaneous ablative cryoimmunotherapy for micrometastaic abscopal effect: No complications. , 2018, Cryobiology.

[8]  T. Choueiri,et al.  Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update , 2018, European journal of cancer.

[9]  C. Drake,et al.  Combining immune check-point blockade and cryoablation in an immunocompetent hormone sensitive murine model of prostate cancer , 2018, Prostate Cancer and Prostatic Diseases.

[10]  S. Hurvitz,et al.  Harnessing the immune system in the battle against breast cancer , 2018, Drugs in context.

[11]  J. Lotz,et al.  Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy , 2018, CardioVascular and Interventional Radiology.

[12]  L. Niu,et al.  Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2‐overexpressing recurrent breast cancer , 2017, Molecular immunology.

[13]  V. Conteduca,et al.  Immunotherapy for Prostate Cancer: Where We Are Headed , 2017, International journal of molecular sciences.

[14]  Robert J. Jones,et al.  Immune checkpoint inhibitors in renal cell carcinoma , 2017, Clinical science.

[15]  L. Melis,et al.  Cryoablation of Primary Breast Cancer in Patients with Metastatic Disease: Considerations Arising from a Single-Centre Data Analysis , 2017, BioMed research international.

[16]  A. Schneeweiss,et al.  317TiPIMpassion131: Phase III study comparing 1L atezolizumab with paclitaxel vs placebo with paclitaxel in treatment-naive patients with inoperable locally advanced or metastatic triple negative breast cancer (mTNBC) , 2017 .

[17]  J. Fütterer,et al.  Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[18]  S. Solomon,et al.  Irreversible electroporation and thermal ablation of tumors in the liver, lung, kidney and bone: What are the differences? , 2017, Diagnostic and interventional imaging.

[19]  E. Galanis,et al.  Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma , 2017, The oncologist.

[20]  Ieva Kurilova,et al.  The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies. , 2017, AJR. American journal of roentgenology.

[21]  J. Erinjeri,et al.  Decision Making in Interventional Oncology: Ablative Options in the Lung , 2017, Seminars in Interventional Radiology.

[22]  Mao Lin,et al.  Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer , 2017, Immunologic Research.

[23]  Yusuke Nakamura,et al.  Characterization of the cryoablation-induced immune response in kidney cancer patients , 2017, Oncoimmunology.

[24]  Kecheng Xu,et al.  Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer , 2017, Oncotarget.

[25]  E. Ziv,et al.  Changes in peripheral blood T-cell balance after percutaneous tumor ablation , 2017, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[26]  Kecheng Xu,et al.  Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer. , 2017, Immunology letters.

[27]  A. Gangi,et al.  Percutaneous image-guided cryoablation: current applications and results in the oncologic field , 2016, Medical Oncology.

[28]  Janice S. Sung,et al.  Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy , 2016, Cancer Immunology Research.

[29]  Janice S. Sung,et al.  A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling , 2016, Clinical Cancer Research.

[30]  Y. Kawakami,et al.  Targeting ALCAM in the cryo-treated tumour microenvironment successfully induces systemic anti-tumour immunity. , 2016, European journal of cancer.

[31]  H. Uehara,et al.  Optimized magnitude of cryosurgery facilitating anti-tumor immunoreaction in a mouse model of Lewis lung cancer , 2016, Cancer Immunology, Immunotherapy.

[32]  Linda K. Han,et al.  A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072 , 2016, Annals of Surgical Oncology.

[33]  Yuan Lu,et al.  The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[34]  H. Korman,et al.  Percutaneous Cryoablation vs Partial Nephrectomy: Cost Comparison of T1a Tumors. , 2016, Journal of endourology.

[35]  F. Abtin,et al.  Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy: The ECLIPSE Trial—Interim Analysis at 1 Year , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[36]  Ronak Talati,et al.  Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. , 2015, Journal of vascular and interventional radiology : JVIR.

[37]  J. G. Lee,et al.  Tumor-Specific Immunity Induced by Cryoablation in a Murine Renal Cell Carcinoma Model , 2014, Korean journal of urology.

[38]  Joyce D. Reyes,et al.  Cryotherapy with concurrent CpG oligonucleotide treatment controls local tumor recurrence and modulates HER2/neu immunity. , 2014, Cancer research.

[39]  N. Agarwal,et al.  Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. , 2014, The Lancet. Oncology.

[40]  D. Dupuy,et al.  Thermal ablation of tumours: biological mechanisms and advances in therapy , 2014, Nature Reviews Cancer.

[41]  E. Vadai,et al.  Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity , 2014, Cancer Immunology, Immunotherapy.

[42]  W. Xiaohua,et al.  Therapeutic outcomes of combining cryotherapy, chemotherapy and DC-CIK immunotherapy in the treatment of metastatic non-small cell lung cancer. , 2013, Cryobiology.

[43]  L. Niu,et al.  Cryotherapy protocols for metastatic breast cancer after failure of radical surgery. , 2013, Cryobiology.

[44]  T. Si,et al.  Analysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancer. , 2013, Asian journal of andrology.

[45]  L. Niu,et al.  Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer. , 2013, World journal of gastroenterology.

[46]  K. Tracey,et al.  Alarmins: awaiting a clinical response. , 2012, The Journal of clinical investigation.

[47]  W. Fang,et al.  Cryoablation Combined with Molecular Target Therapy Improves the Curative Effect in Patients with Advanced Non-Small Cell Lung Cancer , 2011, The Journal of international medical research.

[48]  Hong Wang,et al.  Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma , 2011, PloS one.

[49]  A. Thakur,et al.  Induction of Specific Cellular and Humoral Responses Against Renal Cell Carcinoma After Combination Therapy With Cryoablation and Granulocyte-Macrophage Colony Stimulating Factor: A Pilot Study , 2011, Journal of immunotherapy.

[50]  G. Gravante,et al.  Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. , 2010, American journal of surgery.

[51]  R. van Hillegersberg,et al.  Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model. , 2010, Surgery.

[52]  Adam C. Mues,et al.  Results of kidney tumor cryoablation: renal function preservation and oncologic efficacy , 2010, World Journal of Urology.

[53]  K. Griffith,et al.  Rate of Freeze Alters the Immunologic Response After Cryoablation of Breast Cancer , 2010, Annals of Surgical Oncology.

[54]  M. Sabel,et al.  Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. , 2009, Cryobiology.

[55]  X. Hao,et al.  Combined Cryoablation and GM-CSF Treatment for Metastatic Hormone Refractory Prostate Cancer , 2009, Journal of immunotherapy.

[56]  X. Hao,et al.  Immunologic response to primary cryoablation of high-risk prostate cancer. , 2008, Cryobiology.

[57]  C. Figdor,et al.  In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy. , 2008, Cancer research.

[58]  C. Figdor,et al.  Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity , 2006, British Journal of Cancer.

[59]  C. Figdor,et al.  Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. , 2006, Cancer research.

[60]  B. Tirosh,et al.  Combined Dendritic Cell Cryotherapy of Tumor Induces Systemic Antimetastatic Immunity , 2005, Clinical Cancer Research.

[61]  A. Chang,et al.  Immunologic response to cryoablation of breast cancer , 2005, Breast Cancer Research and Treatment.

[62]  Nina Bhardwaj,et al.  Danger signals: a time and space continuum. , 2004, Trends in molecular medicine.

[63]  A. Gage,et al.  Progress toward Optimization of Cryosurgery , 2004, Technology in cancer research & treatment.

[64]  Ian Finlay,et al.  Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model , 2002, World Journal of Surgery.

[65]  W. Chapman,et al.  Hepatic cryoablation-induced multisystem injury: Bioluminescent detection of NF-κB activation in a transgenic mouse model , 2002, Journal of Gastrointestinal Surgery.

[66]  T. Wobbes,et al.  In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. , 2001, Cryobiology.

[67]  P. Srivastava,et al.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. , 2000, International immunology.

[68]  M. Rivoire,et al.  Cryosurgery as a means to improve surgical treatment of patients with multiple unresectable liver metastases. , 2000, Anticancer research.

[69]  J. Le Bourgeois,et al.  [Whole body irradiation]. , 1989, Pathologie-biologie.

[70]  A. Cooper,et al.  Host responses to cryoablation of normal kidney and liver tissue. , 1978, British journal of experimental pathology.

[71]  R. Ablin.  Cryoimmunotherapy. , 1972, British medical journal.

[72]  D. Wilkins.  Screening for inherited metabolic diseases. , 1972, British medical journal.

[73]  S. Shulman,et al.  Studies in cryo-immunology. II. Tissue and species specificity of the autoantibody response and comparison with iso-immunization. , 1968, Immunology.

[74]  Mole Rh.  Whole body irradiation; radiobiology or medicine? , 1953 .

[75]  M. Liss,et al.  Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. , 2018, Journal of vascular and interventional radiology : JVIR.

[76]  K. Hunt,et al.  Percutaneous ablation in the treatment of breast cancer , 2018 .

[77]  F. Saad,et al.  Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  Y. Har-Shai,et al.  Dermatological Cryosurgery and Cryotherapy , 2016 .

[79]  Z. Guo,et al.  Anti-tumor immunological response induced by cryoablation and anti-CTLA-4 antibody in an in vivo RM-1 cell prostate cancer murine model. , 2014, Neoplasma.

[80]  T. Kazda,et al.  Toxicity and survival outcomes of adjuvant chemoradiation for gastric and gastroesophageal junction cancer patients treated in period 2006-2009: an institutional experience. , 2014, Neoplasma.

[81]  P. Sharma,et al.  Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. , 2010, The Journal of urology.

[82]  Shigeo Tanaka.  Cryosurgery for Malignant Melanoma , 2001 .

[83]  P. Matzinger.  Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[84]  R. Mole.  Whole body irradiation; radiobiology or medicine? , 1953, The British journal of radiology.